News and Media Center

Official updates, analyst briefs, and approved resources for TCS and bioStealthAI.

Summaries are informational. For legal interpretation, consult counsel.

EDITORIAL RESOURCES

Editorial assets and approved materials

Usage note: Approved assets for editorial use. For exceptions, request approval. Do not alter marks, proportions, or colors. Avoid complex backgrounds.

Logo pack thumbnail

Logo pack

SVG, PNG, PDF

Includes light and dark variants and clear-space guide.

Download logos
Boilerplate and fact sheet thumbnail

Boilerplate and fact sheet

PDF

Company overview, TCS definition, contact.

Download fact sheet

Featured

Featured Image

TCS architecture validation field trials

BiostealthAI joins Nvidia Inception to Advance Healthcare AI

LONDON, UK— March 26, 2024 — BiostealthAI® today announced it has joined NVIDIA Inception, a programme that nurtures startups revolutionising industries with technological advancements.

Read the full release

All news

News Image

BioStealthAI joins NVIDIA Inception program

BiostealthAI joins Nvidia Inception to Advance Healthcare AI

LONDON, UK— March 26, 2024 — BiostealthAI® today announced it has joined NVIDIA Inception, a programme that nurtures startups revolutionising industries with technological advancements.

Read more

News Image

BiostealthAI joins London Health Accelerator Programme

BiostealthAI Joins Accelerator Programme to Tackle Health Inequities in London.

LONDON, UK— February 8, 2024 — BiostealthAI®, is thrilled to announce its participation in the London Health Accelerator Programme for Social Enterprise operating in London’s health and life sciences sector. Developed in collaboration between MedCity and the School for Social Entrepreneurs, this programme aims to equip participants with essential skills, mentorship, knowledge, and connections to grow and scale their social enterprises while addressing health disparities in underserved communities.

Read more

News Image

Analyst brief on privacy-first sensing

BiostealthAI Joins the 'Barclays Eagle Labs' Product Growth Programme.

BiostealthAI is proud to announce we've successfully been selected for the Product Growth Programme powered by Barclays Eagle Labs, funded by the UK Government and delivered by Plexal.

Read more

News Image

Usability study on BiostealthAI's flagship device

Usability Study Validates Real-World Application of BiostealthAI's Flagship Touchable Device.

LONDON, UK— December 1, 2023 — BiostealthAI has released the preliminary findings of its ongoing usability study evaluating the effectiveness of its flagship Touchable® device and health management platform. The study is designed to assess the functionality of the hardware and overall usability of the health management platform among elderly individuals suffering from chronic respiratory conditions such as COPD.

Read more

News Image

BiostealthAI usability study announcement

Usability Study of BiostealthAI's Flagship Hardware Device to Commence in September.

BiostealthAI is thrilled to announce its selection for the Simulation for Digital Health (SimDH) programme. Co-funded by the European Regional Development Fund, SimDH offers invaluable support to health tech start-ups and SMEs, empowering them to innovate, develop, and deliver groundbreaking products and services.

Read more